Bogle Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,000
Closed -$291K 342
2020
Q2
$291K Buy
+5,000
New +$269K 0.05% 260
2017
Q4
Sell
-20,395
Closed -$1.07M 375
2017
Q3
$1.07M Buy
20,395
+1,900
+10% +$106K 0.07% 227
2017
Q2
$1.08M Buy
+18,495
New +$961K 0.08% 213
2017
Q1
Sell
-166,898
Closed -$8.78M 397
2016
Q4
$8.78M Buy
166,898
+53,042
+47% +$2.57M 0.61% 66
2016
Q3
$5.08M Buy
+113,856
New +$4.94M 0.37% 95
2016
Q1
Sell
-279,476
Closed -$13.6M 474
2015
Q4
$13.6M Buy
279,476
+19,309
+7% +$859K 0.98% 5
2015
Q3
$10.4M Buy
260,167
+15,844
+6% +$692K 0.74% 48
2015
Q2
$9.8M Buy
244,323
+186,265
+321% +$6.43M 0.73% 40
2015
Q1
$1.9M Buy
+58,058
New +$1.6M 0.13% 196

Other funds holding SYNH

Bogle Investment Management's SYNH Position: Q3 2020 in Review

Bogle Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2020, closing a stake of 5,000 shares — an estimated $291K sold.

Bogle Investment Management first reported a position in SYNH in Q1 2015 and held it in 9 quarters. The position peaked at $13.6M in Q4 2015. 300 funds tracked by Wall St. Rank hold SYNH as of Q3 2020.

  • Bogle Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2020 after selling out during the quarter.
  • Bogle Investment Management sold 5,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2020, an estimated $291K.
  • Bogle Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 9 quarters.
  • Bogle Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $13.6M in Q4 2015.
  • 300 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2020.

Based on Bogle Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.